Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$5.79B
Gross Margin
97.23%
TTM Avg
60.83%
3Y Avg
-170.72%
5Y Avg
-113.81%
Market Cap
$5.87B
Gross Margin
54.49%
TTM Avg
70.12%
3Y Avg
77.23%
5Y Avg
64.22%
Market Cap
$5.61B
Gross Margin
-15.02%
TTM Avg
-3561.64%
3Y Avg
-7339.64%
5Y Avg
-5851.73%
Market Cap
$5.95B
Gross Margin
98.58%
TTM Avg
95.46%
3Y Avg
84.33%
5Y Avg
82.16%
Market Cap
$5.52B
Gross Margin
53.85%
TTM Avg
55.16%
3Y Avg
56.69%
5Y Avg
56.69%
Market Cap
$6.23B
Gross Margin
89.00%
TTM Avg
89.73%
3Y Avg
89.61%
5Y Avg
73.24%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | $5.78B | 0.00% | 0.00% | 0.00% | 0.00% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | 97.23% | 60.83% | -170.72% | -113.81% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 54.49% | 70.12% | 77.23% | 64.22% |
| GRAIL Inc. (GRAL)vs › | $5.89B | -42.52% | -52.32% | -104.24% | -183.56% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -15.02% | -3561.64% | -7339.64% | -5851.73% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 98.58% | 95.46% | 84.33% | 82.16% |
| RadNet, Inc. (RDNT)vs › | $5.53B | 9.70% | 9.04% | 10.84% | 11.30% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 53.85% | 55.16% | 56.69% | 56.69% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | 89.00% | 89.73% | 89.61% | 73.24% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 95.85% | 94.37% | 93.84% | 94.07% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
